全髋关节置换术后30天内早期假体周围股骨骨折并发症与再骨折率极高
本研究基于2010至2022年全国数据库,比较全髋关节置换术后30天内发生假体周围股骨骨折与更晚时间点骨折及无骨折患者的结局。结果显示,早期骨折组90天内并发症显著更高,2年无感染、无再骨折和无翻修生存率均显著低于无骨折组,其中无再骨折生存率仅57.4%。
要点
- THA术后30天内假体周围股骨骨折患者90天并发症显著高于更晚骨折者。
- 早期骨折组2年无再骨折生存率57.4%,无翻修生存率48.5%,均显著低于无骨折组。
- 早期骨折组2年无感染生存率87.8%,显著低于无骨折组的97.7%。
核心结论
- THA术后30天内发生假体周围股骨骨折的患者并发症风险显著高于更晚时间点骨折者。
- 与术后1年内无骨折患者相比,早期骨折组感染、再骨折和再手术风险均显著更高。
研究设计与样本
- 回顾性队列研究,查询大型全付款方国家数据库,纳入2010至2022年行初次THA的患者。
- 早期骨折组(术后30天内骨折)按年龄、性别和合并症负担进行倾向性评分匹配,分别与术后31至90天骨折组(n=1,725)、术后91天至1年骨折组(n=1,887)及术后1年内无骨折组(n=4,465)比较。
- 早期骨折组平均年龄66.63±10.15岁,女性占75%。
- 采用回归分析评估90天和2年结局,并以死亡为竞争终点进行生存分析,评估2年内感染、再骨折和再手术率。
- 证据等级为治疗性III级。
主要发现
- 早期骨折组90天内并发症率显著高于各比较队列。
- 早期骨折组2年无再骨折和无再手术生存率显著低于其他时间点骨折的匹配患者(p<0.05)。
- 早期骨折组2年无感染生存率为87.8%(95%CI 86.8%至88.8%),无骨折组为97.7%(95%CI 97.3%至98.1%)。
- 早期骨折组2年无再骨折生存率为57.4%(95%CI 56.0%至58.9%),无骨折组为99.5%(95%CI 99.3%至99.7%)。
- 早期骨折组2年无再手术生存率为48.5%(95%CI 47.1%至50.0%),无骨折组为97.6%(95%CI 97.2%至98.1%),差异均显著(p<0.05)。
临床怎么用
- 对THA术后30天内发生假体周围股骨骨折的患者,应警惕极高的并发症、再骨折和再手术风险。
- 围手术期和术后应考虑潜在干预措施以降低此类高风险患者的并发症风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to compare the outcomes of patients who underwent a total hip arthroplasty (THA) and sustained a postoperative periprosthetic femoral fracture either within the early postoperative period, within 30 days, or at later time points. METHODS: A large, all-payer national database was queried to identify patients who underwent a primary THA between 2010 and 2022. Patients who underwent a primary THA and sustained a periprosthetic femoral fracture within 30 days postoperatively were propensity-score matched on the basis of age, sex, and comorbidity burden to 3 separate cohorts based on timing: fracture between 31 and 90 days postoperatively (n = 1,725), fracture between 91 days and 1 year (n = 1,887), and no fracture within 1 year (n = 4,465). The 30-day fracture group had a mean age of 66.63 ± 10.15 years, and 75% of patients in this group were female. Regression analyses were utilized to evaluate outcomes at 90 days and 2 years. Survivorship analyses utilizing death as a competing end-point were conducted for rates of infection, refracture, and reoperation at up to 2 years. RESULTS: Patients who sustained a periprosthetic femoral fracture within 30 days after primary THA demonstrated significantly greater rates of complications within 90 days relative to each comparison cohort. The 2-year survivorships free of refracture and reoperation were significantly lower (p < 0.05) for the early fracture cohort relative to matched patients who sustained a fracture at other time points. Additionally, 2-year survivorships were poorer in the ≤30-day cohort than in the comparison cohort who had not sustained a fracture within 1 year postoperatively: survivorships free of infection (87.8% [95% confidence interval (CI), 86.8% to 88.8%] compared with 97.7% [95% CI, 97.3% to 98.1%]), refracture (57.4% [95% CI, 56.0% to 58.9%] compared with 99.5% [95% CI, 99.3% to 99.7%]), and reoperation (48.5% [95% CI, 47.1% to 50.0%] compared with 97.6% [95% CI, 97.2% to 98.1%]) were all significantly lower (p < 0.05). CONCLUSIONS: Patients who sustained an early periprosthetic femoral fracture within 30 days following primary THA were at significantly greater risk for complications than patients who sustained a periprosthetic femoral fracture at later time points. The exceedingly high rates of complications compared with patients without a periprosthetic femoral fracture stresses the importance of not only prevention but potential interventions both perioperatively and postoperatively in an attempt to mitigate the risk of complications for these at-risk patients. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
引用
- Acuña AJ, Forlenza EM, Jones CM, et al. Alarmingly High Rates of Complications and Refracture Among Patients with Early Periprosthetic Femoral Fracture Within 30 Days After THA. J Bone Joint Surg Am. 2026. PMID: 42308497. doi:10.2106/JBJS.25.01355
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。